BIT 0.00% 1.9¢ biotron limited

COVID19 - competitive landscape, page-345

  1. 4,216 Posts.
    lightbulb Created with Sketch. 667
    Where is your evidence that the results didn’t achieve the benchmark lol and this is the reason for the delay lol What a Crock of Shit lol The markers achieved in the 009 clinical phase 2 human trials were better than the company could have anticipated…….Obviously!!! Hence the late acceptance into the Miami conference and the poster award signed off by HIV EXPERTS in the Field. These trials are all about shoring up the end points lol you have to try a little harder if you want to downplay what is actually going on lol
 
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.